Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human TrialsMindMed Reports Full Year 2022 Financial Results and Business HighlightsCybin to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceNuminus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023Irwin Naturals Signs Letter of Intent to Acquire Braxia ScientificNuminus Wellness Inc. Reports Q1 2023 ResultsIrwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical CompanNuminus Develops Mushroom Tea for Use in Psychedelic ResearchIs the Psychedelic Sector Poised for a Comeback?!?PSYC + Nucleus Form New Partnership to Develop and Launch Psychedelic FinderWhat You Need to Know About Numinus Wellness…Numinus provides update on acquisition integration and announces new client financing optionsPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Fourth Consecutive MonthNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022The Psychedelic Sector is Quietly Outperforming the S&P 500PSYC Completes and Publishes 2021 Audited Financials; Will Begin Audit of Q1 & Q2 2022Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PSYC’s Bonfire Platform Development Progresses; Will Host Free Virtual Community Event on August 29th

Florida Patients Have New Hope After Judge Dismisses Challenge

May 27, 2015 • 11:01 PM EDT
2 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

Florida regulators expect to be able to provide registered patients access to a strain of marijuana known as Charlotte’s Web by the end of the year. The strain is non-euphoric and is high in cannabidiol (CBD) and low in tetrahydrocannabinol (THC).

This development comes after Judge W. David Watkins dismissed the claim raised by the owners of Baywood Nurseries of Apopka who alleged that the proposed rule was unfair and vague. After Judge Watkins dismissed their challenge, the Department of Health issued the following statement:

“Today’s ruling allows the department to move forward with implementing the Compassionate Medical Cannabis Act, approved by the legislature in 2014. The department remains committed to ensuring safe and efficient access to this product for children with refractory epilepsy and patients with advanced cancer. We are moving swiftly to facilitate access to the product before the end of the year.”

About 100 nurseries meet the necessary criteria

The Florida Department of Health is expected to start accepting applications from eligible growers within three weeks. The growers could start selling to registered patients who register with the state within months.

Under the Compassionate Medical Cannabis Act of 2014, only Florida nurseries that have been in business for at least 30 years and grow at least 400,000 plants are eligible for one of five licenses to cultivate and sell marijuana.

Under the proposed rule, dispensaries have to prove that they can stay in business for at least two years and be able to cover all costs (i.e. startup costs, bond fees, insurance). The agency will next certify the rule, expected to take about 20 days, and applications would then be submitted within 21 days after that.

Patients have new hope

The Compassionate Medical Cannabis Act of 2014 will provide treatment to people who suffer from diseases such as epilepsy and cancer. Regulators expect that the selected nurseries will commence growing by the end of the summer.

“I am one happy legislator,” said Republican Representative Matt Gaetz who is one of the sponsors of the Compassionate Medical Cannabis Act of 2014. 

Share Share - Facebook Share - Twitter


Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.


Top Stories

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.